583 related articles for article (PubMed ID: 12927382)
1. Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.
Panyam J; Sahoo SK; Prabha S; Bargar T; Labhasetwar V
Int J Pharm; 2003 Aug; 262(1-2):1-11. PubMed ID: 12927382
[TBL] [Abstract][Full Text] [Related]
2. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake.
Sahoo SK; Panyam J; Prabha S; Labhasetwar V
J Control Release; 2002 Jul; 82(1):105-14. PubMed ID: 12106981
[TBL] [Abstract][Full Text] [Related]
3. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression.
Prabha S; Labhasetwar V
Pharm Res; 2004 Feb; 21(2):354-64. PubMed ID: 15032319
[TBL] [Abstract][Full Text] [Related]
4. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
Dong Y; Feng SS
Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
[TBL] [Abstract][Full Text] [Related]
6. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells.
Panyam J; Labhasetwar V
Pharm Res; 2003 Feb; 20(2):212-20. PubMed ID: 12636159
[TBL] [Abstract][Full Text] [Related]
8. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
Avgoustakis K
Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
[TBL] [Abstract][Full Text] [Related]
10. Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA.
Dailey LA; Kleemann E; Wittmar M; Gessler T; Schmehl T; Roberts C; Seeger W; Kissel T
Pharm Res; 2003 Dec; 20(12):2011-20. PubMed ID: 14725368
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
12. Influence of lactide vs glycolide composition of poly (lactic-co-glycolic acid) polymers on encapsulation of hydrophobic molecules: molecular dynamics and formulation studies.
Dobhal A; Srivastav A; Dandekar P; Jain R
J Mater Sci Mater Med; 2021 Sep; 32(10):126. PubMed ID: 34591178
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
Ravi Kumar MN; Bakowsky U; Lehr CM
Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
[TBL] [Abstract][Full Text] [Related]
14. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in-vitro/in-vivo evaluation of surface-modified poly (lactide-co-glycolide) fluorescent nanoparticles.
Pamujula S; Hazari S; Bolden G; Graves RA; Chinta DM; Dash S; Kishore V; Mandal TK
J Pharm Pharmacol; 2010 Apr; 62(4):422-9. PubMed ID: 20604830
[TBL] [Abstract][Full Text] [Related]
17. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
[TBL] [Abstract][Full Text] [Related]
18. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
[TBL] [Abstract][Full Text] [Related]
19. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers.
Qaddoumi MG; Ueda H; Yang J; Davda J; Labhasetwar V; Lee VH
Pharm Res; 2004 Apr; 21(4):641-8. PubMed ID: 15139521
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
